Table 3.
Vaccine | World | African Region | American Region | Eastern Mediterranean Region |
European Region | South-East Asia Region | Western Pacific Region |
---|---|---|---|---|---|---|---|
BCG | −0.3 | 0.1 | −5.0 | −2.1 | 4.2 | 1.2 | 0.2 |
DTP1 | −0.3 | 0 | −3.0 | 0.2 | 0.6 | 1.7 | −0.1 |
DTP3 | 0 | 1.2 | −2.7 | −0.2 | 0.8 | 1.2 | −0.3 |
HepB1 | 3.2 | −5.3 | 7.7 | 0.8 | 1.2 | 5.5 | 5.0 |
HepB3 | 0.3 | 1.6 | −2.5 | −0.2 | 1.3 | 1.2 | −0.3 |
Hib3 | 0.9 | 1.6 | −2.2 | −0.2 | 2.2 | 6.4 | −0.7 |
IPV1 | 28 | 140.5 | 75.6 | 11.9 | 3.3 | 94.9 | 14 |
MCV1 | −0.1 | −0.1 | −1.8 | 0.2 | 0 | 2.8 | 0.3 |
MCV2 | −2.0 | 0 | −4.5 | 1.6 | 0.9 | 6.3 | −6.0 |
PCV3 | 5 | 11.1 | 0.9 | −4.3 | 5.5 | 97.5 | 8.3 |
Pol3 | −0.2 | 0.5 | −2.2 | −0.2 | 0.4 | 1.8 | −1.0 |
RCV1 | −1.4 | −5.4 | −1.8 | −0.2 | 0 | −1.2 | 0.5 |
Rota | 3.8 | 14.5 | −3.5 | −5.0 | −8.3 | − | 41.5 |
BCG: Bacillus Calmette–Guérin vaccine against tuberculosis; DTP1: first dose of diphtheria-tetanus-pertussis vaccine; DTP3: third dose of diphtheria-tetanus-pertussis vaccine; HepB1: first dose of hepatitis B vaccine; HepB3: third dose of hepatitis B vaccine; Hib3: third dose of Haemophilus influenzae vaccine; IPV1: first dose of inactivated poliovirus vaccine; MCV1: first dose of measles-containing vaccine; MCV2: second dose of measles-containing vaccine; PCV3: third dose of pneumococcal conjugate vaccine; Pol3: third dose of polio vaccine; RCV1: first dose of rubella-containing vaccine; Rota: last dose of rotavirus vaccine.